Pharmaceutical

Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.

Aug 31, 2024 - 04:00
GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.
Read the original article

Tags:

Previous Article

Non-infectious Uveitis drugs in development, 2024

Next Article

Generalized Pustular Psoriasis (GPP) drugs in development, 2024

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

EHA 2023: Kura Oncology’s menin inhibitor ziftomenib shows impressive Phase I results

EHA 2023: Kura Oncology’s menin inhibitor ziftomenib sh...

Jun 13, 2023

STAT+: White House AI order calls for crackdown on abuses, harms in health care

STAT+: White House AI order calls for crackdown on abus...

Nov 1, 2023

FDA grants priority review for Zealand Pharma’s dasiglucagon

FDA grants priority review for Zealand Pharma’s dasiglu...

Aug 30, 2023